We are live on ! Find out more
HAIM

Hunter Associates Investment Management Portfolio holdings

AUM $868M
1-Year Est. Return 32.25%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+32.25%
3 Year Est. Return
+76.06%
5 Year Est. Return
+90.53%
10 Year Est. Return
+362.12%
AUM
$238M
AUM Growth
+$3.39M
Cap. Flow
-$3.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
30.82%
Holding
164
New
8
Increased
30
Reduced
66
Closed
3

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.45M
2
PG icon
Procter & Gamble
PG
+$1.01M
3
AMGN icon
Amgen
AMGN
+$509K
4
IBM icon
IBM
IBM
+$451K
5
TROW icon
T. Rowe Price
TROW
+$435K

Sector Composition

Rank Sector Weight
1 Healthcare 24.26%
2 Technology 21.27%
3 Industrials 14.77%
4 Consumer Staples 9.04%
5 Energy 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMC icon
51
FMC
FMC
$1.31B
$1.23M 0.52%
20,408
-1,268
-6% -$65.6K
PNC icon
52
PNC Financial Services
PNC
$100B
$1.08M 0.45%
8,980
COP icon
53
ConocoPhillips
COP
$148B
$1.05M 0.44%
21,126
-1,275
-6% -$61.6K
KMB icon
54
Kimberly-Clark
KMB
$35.9B
$1.05M 0.44%
7,947
ABBV icon
55
AbbVie
ABBV
$438B
$1.04M 0.44%
16,025
BMY icon
56
Bristol-Myers Squibb
BMY
$132B
$995K 0.42%
18,291
-360
-2% -$19.7K
DELL icon
57
Dell
DELL
$296B
$986K 0.41%
54,831
-2,028
-4% -$35.4K
CL icon
58
Colgate-Palmolive
CL
$74.3B
$964K 0.41%
13,175
MDT icon
59
Medtronic
MDT
$114B
$950K 0.4%
11,787
-1,714
-13% -$134K
LLY icon
60
Eli Lilly
LLY
$1.1T
$917K 0.39%
10,903
-225
-2% -$18K
MDR
61
DELISTED
McDermott International
MDR
$883K 0.37%
43,585
-4,800
-10% -$106K
WBA
62
DELISTED
Walgreens Boots Alliance
WBA
$822K 0.35%
9,900
-500
-5% -$41.9K
MRK icon
63
Merck
MRK
$323B
$819K 0.34%
13,502
-27
-0.2% -$1.64K
ADP icon
64
Automatic Data Processing
ADP
$109B
$809K 0.34%
7,900
-900
-10% -$91.8K
WTW icon
65
Willis Towers Watson
WTW
$31.9B
$808K 0.34%
6,170
TPL icon
66
Texas Pacific Land
TPL
$24.2B
$783K 0.33%
25,200
BRK.B icon
67
Berkshire Hathaway Class B
BRK.B
$1.13T
$765K 0.32%
4,587
+150
+3% +$25.1K
RTX icon
68
RTX Corp
RTX
$302B
$757K 0.32%
10,726
+2
+0% +$140
RDS.A
69
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$742K 0.31%
14,320
-461
-3% -$24K
BNY
70
Bank of New York Mellon
BNY
$108B
$725K 0.31%
15,351
-500
-3% -$23.4K
PSX icon
71
Phillips 66
PSX
$86B
$660K 0.28%
8,333
MATW icon
72
Matthews International
MATW
$717M
$657K 0.28%
9,711
SLB icon
73
SLB Ltd
SLB
$78.9B
$653K 0.27%
8,355
-1,225
-13% -$100K
AWK icon
74
American Water Works
AWK
$26.9B
$649K 0.27%
8,350
-300
-3% -$22.3K
STT icon
75
State Street
STT
$51.3B
$640K 0.27%
8,033

Similar funds

Hunter Associates Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Hunter Associates Investment Management held 164 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Hunter Associates Investment Management's Q1 2017 filing shows 8 new, 30 increased, 66 reduced and 3 closed positions. Its largest new stake was Endo International plc: 33,900 shares worth $378K. The largest sale was Pfizer, an estimated $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Hunter Associates Investment Management's largest Q1 2017 buy was Endo International plc: 33,900 shares worth $378K.
  • Hunter Associates Investment Management added most to Weyerhaeuser in Q1 2017, an estimated $1.83M increase.
  • Hunter Associates Investment Management's biggest Q1 2017 reduction was Pfizer, cutting an estimated $1.45M.
  • Hunter Associates Investment Management fully exited NextGen Healthcare, Inc. Common Stock in Q1 2017, selling an estimated $263K.
  • Hunter Associates Investment Management's ten largest holdings make up 31% of its $238M portfolio in Q1 2017.
  • Hunter Associates Investment Management opened 8 new positions and closed 3 in Q1 2017.
  • Hunter Associates Investment Management's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Hunter Associates Investment Management's 13F filing for Q1 2017, filed 10 May 2017.